RT Journal Article
SR Electronic
T1 Evaluating public health effects of risk-based travel policy for the COVID-19 epidemic in Scotland
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2023.08.20.23293987
DO 10.1101/2023.08.20.23293987
A1 McLachlan, Isobel
A1 Huntley, Selene
A1 Leslie, Kirstin
A1 Bishop, Jennifer
A1 Redman, Christopher
A1 Yebra, Gonzalo
A1 Shaaban, Sharif
A1 Christofidis, Nicolaos
A1 Lycett, Samantha
A1 Holden, Matthew T.G.
A1 Robertson, David L.
A1 Smith-Palmer, Alison
A1 Hughes, Joseph
A1 Nickbakhsh, Sema
YR 2023
UL http://medrxiv.org/content/early/2023/08/21/2023.08.20.23293987.abstract
AB Background Decisions to impose temporary travel measures are less common as the global epidemiology of COVID-19 evolves. Risk-based travel measures may avoid the need for a complete travel ban, however evaluations of their effects are lacking. Here we investigated the public health effects of a temporary traffic light system introduced in the United Kingdom (UK) in 2021, imposing red-amber-green (RAG) status based on risk assessment.Methods We analysed data on international flight passengers arriving into Scotland, COVID-19 testing surveillance, and SARS-CoV-2 whole genome sequences to quantify effects of the traffic light system on (i) international travel frequency, (ii) travel-related SARS-CoV-2 case importations, (iii) national SARS-CoV-2 case incidence, and (iv) importation of novel SARS-CoV-2 variants.Results International flight passengers arriving into Scotland had increased by 754% during the traffic light period. Amber list countries were the most frequently visited and ranked highly for SARS-CoV-2 importations and contribution to national case incidence. Rates of international travel and associated SARS-CoV-2 cases varied significantly across age, health board, and deprivation groups. Multivariable logistic regression revealed SARS-CoV-2 cases detections were less likely among travellers than non-travellers, although increasing from green-to-amber and amber-to-red lists. When examined according to travel destination, SARS-CoV-2 importation risks did not strictly follow RAG designations, and red lists did not prevent establishment of novel SARS-CoV-2 variants.Conclusions Our findings suggest that country-specific post-arrival screening undertaken in Scotland did not prohibit the public health impact of COVID-19 in Scotland. Travel rates likely contributed to patterns of high SARS-CoV-2 case importation and population impact.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by the Chief Scientist Office Response Mode funding [HIPS/21/63]. The MRC-University of Glasgow authors are supported by the Medical Research Council [MC_UU_12014/12].Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was undertaken as part of public health surveillance activity within the COVID-19 programme of Public Health Scotland, in line with the necessary associated regulations and guidelines. The retention and processing of information on individuals is conducted by Public Health Scotland as part of COVID-19 surveillance in Scotland in the context of emergency data processing (https://www.informationgovernance.scot.nhs.uk/covid-19-privacy-statement/), including the Civil Contingencies Act 2004, the NHS (Scotland) Act 1978 and the Public Health (Scotland) Act 2008, and under Articles 6(1)(e), 9(2)(h), 9(2)(i), 9(2)(j) of the General Data Protection Regulation. Surveillance data was shared with NHS Scotland according to the Intra NHS Scotland Data Sharing Accord (https://www.informationgovernance.scot.nhs.uk/wp-content/uploads/2020/06/2020-06-17-Intra-NHS-Scotland-Sharing-Accord-v2.0.pdf). Ethics approval and informed consent was not required for this work which was based on pre-existing infectious disease surveillance data for the Scottish population. The access and processing of data was conducted under standard Data Protection Impact Assessment information governance approval. Individual-level records were de-identified before being accessed and analysed by the project teamI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesThe healthcare data used in this study are available upon application to the NHS Scotland Public Benefit and Privacy Panel For Health and Social Care: https://www.informationgovernance.scot.nhs.uk/pbpphsc/. International flight data may be sourced from the Civil Aviation Authority (https://www.caa.co.uk/home/); see also: https://www.caa.co.uk/data-and-analysis/uk-aviation-market/airports/uk-airport-data/.